Journals / Ankara Medical Journal / 2020 / Cilt: 20 - Sayı: 2

COVID-19 IN PRIMARY HEALTHCARE

BİRİNCİ BASAMAKTA COVID-19

Pages
444–467
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For all these reasons, we aimed to examine the family health centers coping withCOVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The coronaviruses are a large family of viruses infecting animals or humans and causing diseases, includingMiddle East Respiratory Syndrome(MERS, MERS-CoV) and Severe Acute Respiratory Syndrome(SARS, SARSCoV).
📊
Key Findings & Data:The novel coronavirus SARS-CoV-2 emerged in December 2019 at the city of Wuhan, affecting therespiratory system leading to pneumonia, pulmonary edema, Acute Respiratory Distress Syndrome,multiorgan failure, and death.
💡
Conclusion & Impact:For all these reasons, we aimed to examine the family health centers coping withCOVID-19.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

The coronaviruses are a large family of viruses infecting animals or humans and causing diseases, includingMiddle East Respiratory Syndrome(MERS, MERS-CoV) and Severe Acute Respiratory Syndrome(SARS, SARSCoV). The novel coronavirus SARS-CoV-2 emerged in December 2019 at the city of Wuhan, affecting therespiratory system leading to pneumonia, pulmonary edema, Acute Respiratory Distress Syndrome,multiorgan failure, and death. Treatment studies are still ongoing, but hydroxychloroquine, azithromycin,oseltamivir, favipiravir with some other anti-virals, and convalescent plasma therapy are prominent. Themortality rate of disease is 3.8% in the world, infesting many countries. Legal regulations have been made forthe public to reduce transmission. Family health centers are providing healthcare services to every individual,for example, children, pregnant, patients with chronic diseases, patients with any complaint, and individualswho applied for health papers. In such a pandemic family, physicians also have to restrain the transmission ofviruses between those people who applied. Therefore triage is needed to determine the high-risk patients assoon as possible. Both of them and other patients are protected in that way. After the filiation is done, suspectedcases or COVID-19 contacted cases are kept in touch by family physicians to follow up their clinical status andcheck for isolation conditions. For all these reasons, we aimed to examine the family health centers coping withCOVID-19.

Özet

Koronavirüsler, hayvanları veya insanları enfekte edebilen ve Orta Doğu Solunum Sendromu (MERS) ve Şiddetli Akut Solunum Sendromu (SARS) gibi hastalıklara neden olan büyük bir virüs ailesidir. Yeni koronavirüs (SARS-CoV-2) Aralık 2019'da Wuhan şehrinde ortaya çıkan ve pnömoni, pulmoner ödem, ARDS, multiorgan yetmezliği ve ölüme sebebiyet verebilen bir solunum yolu enfeksiyon etkenidir. Tedavi çalışmaları devam etmekle birlikte şu an hidroksiklorokin, azitromisin, plazma tedavisi ve favipiravir gibi anti-viraller öne çıkan tedavilerdir. Hastalığın ölüm oranı %3,8'dir. Yayılımın azalmasını sağlamak amacıyla yasal düzenlemeler yapılmıştır. Aile sağlığı merkezleri (ASM) çocuk, gebe, yaşlı, kronik hastalığı olan hastalar ve birtakım sağlık belgeleri için başvuran kişilere hizmet veren birinci basamak sağlık kurumlarıdır. Pandemi varlığında aile hekimleri, ASM’lere başvuran kişiler arasında virüs iletimini kısıtlamak zorundadır. Bu nedenle triaj yapılması yüksek riskli hastaları mümkün olan en kısa sürede saptamak için gereklidir. ASM’lere başvuran tüm hastalar bu şekilde korunabilir. Filyasyon yapıldıktan sonra, şüpheli vakalar veya COVID-19 ile temas eden vakalar aile hekimleri tarafından klinik durumlarının takip edilmesi ve izolasyon koşullarının kontrol edilmesi amacıyla günlük olarak takip edilmektedir. Tüm bu nedenlerden ötürü, COVID-19 ile mücadele eden aile sağlığı merkezlerini incelemeyi amaçladık.

🔖

Cite This Article

ÖZTÜRK, G. Z., ARICA, S., ACAR, H., GÖKSEVEN, Y. (2022). COVID-19 IN PRIMARY HEALTHCARE. Ankara Medical Journal, Cilt: 20 - Sayı: 2, 444–467. https://ajindex.com/articles/441779

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. World Health Organisation Department of Communicable Disease Surveillance and Response. WHO guidelines for the global surveillance of severe acute respiratory syndrome ( SARS ) 2004. [Internet]. https://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2004_1.pdf (Access Date: 04.04.2020
  2. Sampathkumar, Priya Temesgen Z, Smith TF, Thompson RL. SARS: Epidemiology, Clinical Presentation, Management, and Infection Control Measures. Mayo Clin Proc 2003;78:882 –90
  3. World Health Organisation. Middle East respiratory syndrome coronavirus (MERS-CoV) 2019 [Internet]. https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus- (mers-cov) (Access Date: 06.04.2020
  4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506
  5. World Health Organisation. Laboratory testing for coronavirus disease ( COVID-19 ) in suspected human cases. 2020. [Internet]. https://apps.who.int/iris/bitstream/handle/10665/331501/WHO-COVID-19- laboratory-2020.5-eng.pdf (Access Date: 31.03.2020
  6. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514–23
  7. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565–74
  8. Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020;382(1):1564–7
  9. Aylward, Bruce (WHO); Liang W (PRC). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 2020. [Internet]. http://www.who.int/docs/default-source/coronaviruse/who-chinajoint-mission-on-covid-19-final-report.pdf (Access Date: 06.04.2020
  10. Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M, et al. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020. Morb Mortal Wkly Rep 2020;69(9):245–6
  11. Wei WE, Li Z, Chiew CJ, Yong SE, Toh MP, Lee VJ. Presymptomatic Transmission of SARS-CoV-2. Morb Mortal Wkly Rep 2020;69(14):411–5
  12. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395(10223):